XML 63 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Details) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities $ (8,684) $ 3,467
Net cash (used) provided by operating activities 86,821 66,769
Investing Activities:    
Capital expenditures (16,384) (9,795)
Net cash used in investing activities (25,068) (6,328)
Financing Activities:    
Proceeds from (Repayments of) Bank Overdrafts (9,408) 155
Payments for Repurchase of Common Stock (1,891) (56,665)
Proceeds from (Payments for) Other Financing Activities (550) (768)
Net cash used in financing activities (63,749) (86,538)
Effect of exchange rate changes on cash and cash equivalents (5,017) 3,765
Net change in cash and cash equivalents (7,013) (22,332)
Cash and cash equivalents at the beginning of period 117,953 110,131
Cash and cash equivalents at the end of period 110,940 87,799
Parent Company [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities 0 0
Net cash (used) provided by operating activities 9,878 9,117
Investing Activities:    
Capital expenditures 0 0
Proceeds from Dividends Received 0 0
Net cash used in investing activities 0 0
Financing Activities:    
Borrowings 0 47,548
Repayments (7,987) 0
Proceeds from (Repayments of) Bank Overdrafts 0 0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Payments for Repurchase of Common Stock (1,891)  
Proceeds from (Payments for) Other Financing Activities 0 0
Net cash used in financing activities (9,878) (9,117)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 0 0
Cash and cash equivalents at the beginning of period 0 0
Cash and cash equivalents at the end of period 0 0
Guarantor Subsidiaries [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities (37,524) (72,761)
Net cash (used) provided by operating activities 31,192 73,130
Investing Activities:    
Capital expenditures (9,334) (4,259)
Proceeds from Dividends Received 95,511 33,818
Net cash used in investing activities 48,653 (43,202)
Financing Activities:    
Borrowings 191,888 313,749
Repayments (260,888) (348,478)
Proceeds from (Repayments of) Bank Overdrafts 0  
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Payments for Repurchase of Common Stock   0
Payments for Repurchase of Private Placement 0  
Proceeds from (Payments for) Other Financing Activities (9,958) (613)
Net cash used in financing activities (78,958) (35,342)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 887 (5,414)
Cash and cash equivalents at the beginning of period 50,602 41,552
Cash and cash equivalents at the end of period 51,489 36,138
Non-Guarantor Subsidiaries [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities (8,684) 12,322
Net cash (used) provided by operating activities 45,751 (15,478)
Investing Activities:    
Capital expenditures (7,050) (5,536)
Proceeds from Dividends Received 0 0
Net cash used in investing activities (15,734) 6,786
Financing Activities:    
Borrowings 736,372 442,674
Repayments (673,761) (420,847)
Proceeds from (Repayments of) Bank Overdrafts 0 0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees (95,511) (33,818)
Payments for Repurchase of Common Stock 0 0
Proceeds from (Payments for) Other Financing Activities 0 0
Net cash used in financing activities (32,900) (11,991)
Effect of exchange rate changes on cash and cash equivalents (5,017) 3,765
Net change in cash and cash equivalents (7,900) (16,918)
Cash and cash equivalents at the beginning of period 67,351 68,579
Cash and cash equivalents at the end of period 59,451 51,661
Consolidated Entities [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities (8,684) 3,467
Net cash (used) provided by operating activities 86,821 66,769
Investing Activities:    
Capital expenditures (16,384) (9,795)
Proceeds from Dividends Received 0 0
Net cash used in investing activities (25,068) (6,328)
Financing Activities:    
Borrowings 882,749 731,335
Repayments (934,649) (760,595)
Proceeds from (Repayments of) Bank Overdrafts 0 0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Payments for Repurchase of Common Stock 1,891 56,665
Proceeds from (Payments for) Other Financing Activities (9,958) (613)
Net cash used in financing activities (63,749) (86,538)
Effect of exchange rate changes on cash and cash equivalents (5,017) 3,765
Net change in cash and cash equivalents (7,013) (22,332)
Cash and cash equivalents at the beginning of period 117,953 110,131
Cash and cash equivalents at the end of period 110,940 87,799
Consolidation, Eliminations [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities 37,524 63,906
Net cash (used) provided by operating activities 0 0
Investing Activities:    
Capital expenditures 0 0
Proceeds from Dividends Received (95,511) (33,818)
Net cash used in investing activities (57,987) 30,088
Financing Activities:    
Borrowings (45,511) (72,636)
Repayments (7,987) (8,730)
Proceeds from (Repayments of) Bank Overdrafts 0 0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees (95,511) (33,818)
Payments for Repurchase of Common Stock 0 0
Proceeds from (Payments for) Other Financing Activities 0 0
Net cash used in financing activities 57,987 (30,088)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 0 0
Cash and cash equivalents at the beginning of period 0 0
Cash and cash equivalents at the end of period $ 0 $ 0